Menu
Recruiting NCT06276426

Plants Optimizing Development Study (PODS)

No phase Interventional Healthy Children

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Soy foods, Non-Soy Plant-Based Foods.
Who it may be relevant to
Registry conditions: Healthy Children. Basic parameters: 8 years — 11 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Plants Optimizing Development Study

Overview

This study aims to conduct a randomized clinical trial to measure the effects of a 3-month daily mixed-soy food intervention vs. a control group receiving isocaloric foods on reproductive hormones, body composition, metabolic risk, fecal microbiota, and cognition among 8-11-year-old children. Additionally, this study will assess soy food intake immediately following participation in the clinical trial to determine changes in soy food acceptance in children.

Detailed description

The central hypothesis is that greater soy isoflavone consumption does not alter sex steroid levels but is associated with beneficial clinical outcomes of body composition, metabolic health, and gut-brain axis among pre- and early adolescents.

Interventions

  • Other Soy foods
    Soy milk, soy yogurt, tofu, tempeh, soy nuts, edamame, soy protein bar, and soy-based frozen meat substitutes.
  • Other Non-Soy Plant-Based Foods
    Pea milk, almond milk yogurt, chickpeas, chickpea chips, lentil chips, non-soy protein bar, and non-soy based frozen meat substitutes.

Primary outcome measures

  • Sex steroid excretion [Time frame: 3 months (Baseline vs Follow-up)]
Secondary outcome measures (8)
  • Gut microbiota [Time frame: 3 months (Baseline vs Follow-up)]
  • Attentional Accuracy [Time frame: 3 months (Baseline vs Follow-up)]
  • Attentional Reaction Time [Time frame: 3 months (Baseline vs Follow-up]
  • Hippocampal-dependent Relational memory [Time frame: 3 months (Baseline vs Follow-up)]
  • Body Composition [Time frame: 3 months (Baseline vs Follow-up)]
  • Metabolic Markers [Time frame: 3 months (Baseline vs Follow-up)]
  • Pubertal Staging [Time frame: 3 months (Baseline vs Follow-up)]
  • Cognitive Abilities and Academic Achievement [Time frame: 3 months (Baseline vs Follow-up)]

Eligibility criteria

Inclusion criteria

  • Child assent and parent/guardian consent
  • Free of any food allergy
  • 8-11 years of age
  • Tanner scale score of ≤ 2
  • 20/20 or corrected vision
  • No antibiotic usage in the past 3 months
  • ≤1 serving/d of soy food habitual consumption

Exclusion criteria

  • Non-assent or consent by child assent and/or parent/guardian
  • Presence of any food allergy
  • Younger than 8 years or older than 11 years
  • Presence of specific neurological and genetic disorders (i.e., Autism, Cerebral Palsy, Multiple Sclerosis, Down syndrome)
  • Presence of endocrine, metabolic, and gastrointestinal disease e.g., hypertension, diabetes, celiac disease
  • Tanner scale score of > 2
  • Not 20/20 or uncorrected vision
  • Antibiotic usage in the past 3 months
  • >1 serving/d of soy food habitual consumption

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • University of Illinois — Urbana

Identifiers

NCT: NCT06276426 · 24468

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗